Previous close | 0.2080 |
Open | 0.2080 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.2080 - 0.2080 |
52-week range | 0.1310 - 0.2300 |
Volume | |
Avg. volume | 42 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Drugmakers are in a race to develop vaccines and drugs to treat respiratory diseases caused by respiratory syncytial virus and COVID-19, resulting in increased demand for clinical testing of the products. The contract research organisation now expects its annual revenue to be 55 million pounds ($68.8 million), compared with 53 million pounds it previously expected.